medigraphic.com
ISSN 1727-897X (Electronic)

2022, Number 3

<< Back Next >>

Medisur 2022; 20 (3)

Evaluation of personality disorders. A systematic review

Pérez LBD, Jiménez PE

Language: Spanish
References: 44
Page: 441-454
PDF size: 405.72 Kb.


ABSTRACT

Background: In the personality disorders evaluation context, the proper use of each of the existing instruments to carry it out is relevant. Thus, full knowledge of the psychometric properties is necessary.
Objective: to describe studies that evaluates personality disorders through the use of instruments.
Methods: a systematic review was carried out, through the PRISMA Statement, in the Cochrane, PubMed, Scielo, EBSCO, and PsycInfo databases, from October to December 2019. A total of 183 articles were considered eligible. After applying the selection criteria, the sample comprised 12 articles.
Results: the Dimensional Clinical Personality Inventory was the most used, which was found in the three types of articles included; mainly in studies of adaptation and validation of assessment instruments for personality disorders (also in version 2); as well as the Personality Inventory for DSM-5.
Conclusion: The developed review was characterized by its heterogeneity, and evidenced the lack of consensus in the scientific community, about which instruments are the most suitable for the assessment of personality disorders today.


REFERENCES

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. V ed. United States: APA; 2013.

  2. Organización Panamericana de la Salud. Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud. 10 ed. Washington, D.C: OMS; 1995.

  3. Sheehan L, Nieweglowski K, Corrigan P. The Stigma of Personality Disorders. Curr Psychiatry Rep. 2016;18(1):11.

  4. Winsper C, Bilgin A, Thompson A, Marwaha S, Chanen AM, Singh SP, et al. The prevalence of personality disorders in the community: a global systematic review and meta-analysis. Br J Psychiatry. 2020;216(2):69-78.

  5. Bergner RM. What is personality? Two myths and a definition. New Ideas Psychol. 2020;57:100759.

  6. Champel AM. Reorganización estructural de los trastornos de personalidad y medición de su significación clínica[Tesis]. Bellaterra, España: Universidad Autónoma de Barcelona; 2018[citado 15/09/2021]. Disponible en: Disponible en: https://dialnet.unirioja.es/servlet/tesis?codigo=272934 6.

  7. Riddle M, Meeks T, Alvarez C, Dubovsky A. When personality is the problem: Managing patients with difficult personalities on the acute care unit. J Hosp Med. 2016;11(12):1-6.

  8. Dhillon S, Bagby RM, Kushner SC, Burchett D. The impact of underreporting and overreporting on the validity of the Personality Inventory for DSM-5 (PID-5): A simulation analog design investigation. Assessment. 2017;29(4):473.

  9. Kelley SE, Balsis S, Smith ST, Edens JF, Douglas KS, Poythress Jr NG. A dimensional comparison of a self-report and a structured interview measure of conduct disorder. J Pers Disord. 2016;30(2):232-41.

  10. Samuel DB, Bucher MA. Assessing the assessors: The feasibility and validity of clinicians as a source for personality disorder research. Personal Disord. 2017;8(2):104.

  11. Quirk SE, Berk M, Chanen AM, Koivumaa-Honkanen H, Brennan-Olsen SL, Pasco JA, et al. Population prevalence of personality disorder and associations with physical health comorbidities and health care service utilization: A review. Personal Disord. 2016;7(2):136.

  12. Huttona B, Catalá F, Mohera D. La extensión de la declaración PRISMA para revisiones sistemáticas que incorporan metaanálisis en red: PRISMA-NMA. Med Clin. 2016;14(6):262-6.

  13. Green S, Higgins JPT, Alderson P, Clarke M, Mulrow CD. Cochrane handbook for systematic reviews of interventions. 5.0.1 ed. London: Cochrane Library; 2011.

  14. Martin J, Walcott G, Clarke TR, Barton EN, Hickling FW. The Prevalence of Personality Disorder in a General Medical Hospital Population in Jamaica. West Indian Med J. 2013;62(5):463-7.

  15. Walcott G, Martin J, Hickling FW. The Prevalence of Personality Disorder in a Psychiatric and Substance Abuse Population in Jamaica. West Indian Med J. 2013;62(5):458.

  16. Samuel DB, Añez LM, Paris M, Grilo CM. The Convergence of Personality Disorder Diagnoses Across Different Methods Among Monolingual (Spanish-Speaking Only) Hispanic Patients in Substance Use Treatment. Personal Disord. 2014;5(2):172-7.

  17. Carvalho LF, Arruda W. Assessment of Pathological Personality traits in Meditation Practitioners and Non-practitioners. Psychol Assess. 2018;28(e2804):1-10.

  18. Belli H, Belli S, Ural C, Akbudak M, Oktay MF, Akyuz EF, et al. Psychopathology and Psychiatric Co-morbidities in Patients Seeking Rhinoplasty for Cosmetic Reasons. West Indian Med J. 2013;62(5):481-6.

  19. Robles H, Mata JL, Sánchez MB, Vera MN, Pegalajara J, Mezcuac A, et al. Coocurrencia de trastornos de personalidad en pacientes con trastornos de ansiedad. Revista de Psicología Universidad de Chile. 2016;25(1):1-17.

  20. Carvalho LF, Arruda W. Association between anxiety and depression symptoms with pathological personality traits. Psicol Caribe. 2016;33(2):133-45.

  21. Carvalho LF, Pianowski G. Revision of the Dependency Dimension of the Dimensional Clinical Personality Inventory. Paidéia. 2015;25(60):57-65.

  22. Katz R, Carvalho LF, Myung SJ, Yazigi L. Validity Evidences for the Dimensional Clinical Personality Inventory in Outpatient Psychiatric Sample. Paidéia. 2015;25(61):221-28.

  23. Carvalho LF, Pianowski G, Reis AM. Development and Diagnostic Accuracy of the Screening of the Dimensional Clinical Personality Inventory. Psicol Ciênc Prof. 2017;37(4):1011-24.

  24. Carvalho LF, Sette CP, Ferrari BL. Development of a Scale to Measure Histrionic Traits According to the Hierarchical Taxonomy of Psychopathology. Trends Psychol. 2019;27(3):707-20.

  25. Suzuki T, Samuel DB, Pahlen S, Krueger RF. DSM-5 Alternative Personality Disorder Model Traits as Maladaptive Extreme Variants of the Five-Factor Model: An Item-Response Theory Analysis. J Abnorm Psychol. 2015;124(2):343-54.

  26. Torres JF, Moya FJ, Giner CA, Oliveras MA. Inventario PID-5, perfil dimensional del DSM-5 para orientar el diagnóstico y las necesidades terapéuticas en los trastornos de personalidad. An psicol. 2019;35(1):47-57.

  27. Palomares N, McMaster A, Díaz M, de la Vega I, Montes A, Carrasco JL. Comorbilidad con el eje II y funcionalidad en pacientes graves con trastorno límite de la personalidad. Actas Esp Psiquiatr[Internet]. 2016[citado 15/09/2021];44(6):[aprox. 10p]. Disponible en: https://medes.com/publication/11737827. .

  28. Carvalho LF, Primi R. Prototype matching of personality disorders with the Dimensional Clinical Personality Inventory. Psic Teor Pesq. 2016;32(2):1-9.

  29. Carvalho LF, Balbino BD, Primi R. Psychometric properties of the revised conscientiousness dimension of Inventário Dimensional Clínico da Personalidade (IDCP). Trends Psychiatry Psychother. 2014;36(24):23-31.

  30. Carvalho LF, Arruda W. Revisión de la dimensión aislamiento del Inventario Dimensional Clínico de Personalidad. Temas Psicol. 2016;24(1):47-61.

  31. Carvalho LF, Martins DF. Revisão da dimensão desconfiança do Inventário Dimensional Clínico da Personalidade Psico[Internet]. 2017[citado 15/09/2021];48(2):[aprox. 20p]. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=607296931.

  32. Carvalho LF, Sette CP. Revision of the Criticism Avoidance dimension of the Dimensional Clinical Personality Inventory. Estud Psicol. 2017 34(2):219-31.

  33. Carvalho LF. Review Study of the Impulsiveness Dimension of the Dimensional Clinical Personality Inventory. Univ Psychol. 2018;17(1):1-11.

  34. Al-Dajani N, Gralnick TM, Bagby RM. A Psychometric Review of the Personality Inventory for DSM-5 (PID-5): Current Status and Future Directions. J Pers Assess. 2016;98(1):62-81.

  35. Bastiaens T, Claes L, Smits D, Clercq BD, Fruyt FD, Rossi G, et al. The Construct Validity of the Dutch Personality Inventory for DSM-5 Personality Disorders (PID-5) in a Clinical Sample. Assessment. 2016;23(1):42-51.

  36. Gutiérrez F, Aluja A, Peri JM, Calvo N, Ferrer M, Baillés E, et al. Psychometric Properties of the Spanish PID-5 in a Clinical and a Community Sample. Assessment. 2017;24(3):326-36.

  37. Ferrer A, Londoño NH, Calvete E, Krueger RF. Las propiedades psicométricas del Inventario de Personalidad para el DSM-5 (PID-5) en población clínica colombiana. Univ Psychol[Internet]. 2019[citado 15/09/2021];18(1):[aprox. 30p]. Disponible en: https://revistas.javeriana.edu.co/index.php/revPsycho/article/download/18602/2156837.

  38. Sanchez RO, Montes SA, Somerstein LD. Inventario de Personalidad para el DSM-5: propiedades psicométricas en población argentina. Estudio preliminar. Interdisciplinaria[Internet]. 2020[citado 15/09/2021];37(1):[aprox. 34p]. Disponible en: http://www.ciipme-conicet.gov.ar/ojs/index.php?journal=interdisciplinaria&page=article&op=download&path%5B%5D=379&path%5B%5D=pdf38.

  39. Watters CA, Bagby RM. A meta-analysis of the five-factor internal structure of the Personality Inventory for DSM-5. Assessment. 2018;30(9):1255-60.

  40. Bel AMB-F, Osório FL. The Personality Inventory for DSM-5: Psychometric Evidence of Validity and Reliability-Updates. Harv Rev Psychiatry. 2020;28(4):225-37.

  41. Reed GM. Progress in developing a classification of personality disorders for ICD-11. World Psychiatry. 2018;17(2):227.

  42. World Health Organization. ICD-11 Clinical Descriptions and Diagnostic Guidelines for Mental and Behavioural Disorders[Internet]. Geneva: WHO; 2018[citado 15/09/2021]. Disponible en: https://gcp.network/en/private/icd-11guidelines/disorders

  43. Bach B, First MB. Application of the ICD-11 classification of personality disorders. BMC Psychiatry. 2018;18(1):1-14.

  44. Pires R, Henriques J, Sousa A, Bach B, Paulino M, Gama J, et al. The Utility of ICD-11 and DSM-5 Traits for Differentiating Patients With Personality Disorders From Other Clinical Groups. Front Psychiatry[Internet]. 2021[citado 15/09/2021];12:[aprox. 14p]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085522/pdf/fpsyt-12-633882.pdf44.




2020     |     www.medigraphic.com